Full event guide

Download the Neuroimmunology Drug Development Brochure

Annotation 2020-01-23 135606

What's New for 2020?

This year, the 2nd Neuroimmunological Drug Development Summit will have a shifted focus on the translational challenges of developing neurodegenerative therapeutics targeting neuroimmunological mechanisms as the leading drug developers in the space progress into the clinic.

With 22 fresh speakers, the agenda will also cover the potential for targeting astrocytes and inflammasome-mediated pathways.

 

Companies joining us in 2020 include: Astellas, Roche, Janssen, Alzheimer’s Association, Michael J Fox, INmune, Lundbeck, Alchemab